Efficacy of minimally invasive transthoracic closure of atrial and ventricular septal defects_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

MENG Xiongwei ¹ ,  YANG Siyuan ² , HU Xuanyi ² , JIANG Tian ²

1. Guizhou Medical University, Guiyang, 550004, P.R.China;
2. Department of Cardiac Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, P.R.China;

Corresponding?author：

YANG Siyuan, Email: 15772955@qq.com

Keywords：

Atrial septal defect; ventricular septal defect; minimally invasive; surgical occlusion procedure; complication

DOI：

10.7507/1007-4848.201708049

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To evaluate the efficacy and safety of transthoracic minimally invasive occlusion operation for the treatment of congenital atrial and ventricular septal defects. Methods The clinical data of 88 patients who underwent surgical occlusion operation from December 2015 to February 2017 were summarized. There were 52 males and 36 females, aged 6.8±7.5 years ranging from 1.6 to 24.0 years. All the patients were followed up by ultrasound and electrocardiogram at postoperative 3, 6 and 12 months. The efficacy of minimally invasive thoracotomy was analyzed by statistical methods. Results The patients were followed up for 3-15 (6.8±2.3) months, and the follow-up rate was 92.0%. Ultrasound showed occluder fixed well and no residual shunt, valve regurgitation, thrombosis or other complications occurred. The heart was reduced, the ejection fraction was greater than 55%, and heart function rating for all patients was grade Ⅰ. Conclusion Transthoracic mini-invasive surgical occlusion of atrial and ventricular septal defects is safe and effective. The short and middle-term effect is satisfying. It can be widely used in clinical, but multi-center and long-term follow-up and assessment still need to be carried out.

Citation： MENG Xiongwei, YANG Siyuan, HU Xuanyi, JIANG Tian. Efficacy of minimally invasive transthoracic closure of atrial and ventricular septal defects. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2018, 25(8): 715-718. doi: 10.7507/1007-4848.201708049 Copy

1.	中國醫師協會心血管外科醫師分會. 經胸微創室間隔缺損封堵術中國專家共識. 中華胸心血管外科雜志, 2011, 27(9): 516-518.
2.	Masura J, Gavora P, Formanek A, et al. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn, 1997, 42(4): 388-393.
3.	萬連壯, 應朝暉, 姜萬維, 等. 食道超聲引導下小切口室間隔缺損封堵術的療效分析. 中國微創外科雜志, 2010, 10(11): 1024-1025.
4.	Carminati M, Butera G, Chessa M, et al. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J, 2007, 28(19): 2361-2368.
5.	朱達, 賃可, 馮沅, 等. 雜交技術治療嬰幼兒及兒童肌部室間隔缺損——華西醫院經驗. 中國胸心血管外科臨床雜志, 2015, 20(2): 118-122.
6.	邢泉生. 經胸微創封堵室間隔缺損遠期結果——附615例6年隨訪. 中國循環雜志, 2013, 28(s1): 198-199.
7.	Liang T, XiangJun Z, XiaoJing M, et al. New minimally invasive technique to occlude secundum atrial septal defect in 53 patients. Ann Thorac Surg, 2006, 81(4): 1417-1419.
8.	Lin K, Zhu D, Tao K, et al. Hybrid perventricular device closure of doubly committed subarterial ventricular septal defects: mid-term results. Catheter Cardiovasc Interv, 2013, 82(3): E225-E232.
9.	Matyal R, Wang A, Mahmood F. Percutaneous ventricular septal defect closure with amplatzer devices resulting in severe tricuspid regurgitation. Catheter Cardiovasc Interv, 2013, 82(6): E817-E820.
10.	Holzer RJ, Sallehuddin A, Hijazi ZM. Surgical strategies and novel alternatives for the closure of ventricular septal defects. Expert Rev Cardiovasc Ther, 2016, 14(7): 831-841.
11.	Yang Y, Gao L, Xu X, et al. Echocardiographic assessment and guidance in minimally invasive surgical device closure of perimembranous ventricular septal defects. Heart Surg Forum, 2014, 17(4): E206-E211.
12.	Lee WC, Fang CY, Huang CF, et al. Predictors of atrial septal defect occluder dislodgement. Int Heart J, 2015, 56(4): 428-431.
13.	Zhou D, Pan W, Guan L, et al. Transcatheter closure of perimembranous and intracristal ventricular septal defects with the SHSMA occluder. Catheter Cardiovasc Interv, 2012, 79(4): 666-674.
14.	Tao K, Lin K, Shi Y, et al. Perventricular device closure of perimembranous ventricular septal defects in 61 young children: early and midterm follow-up results. J Thorac Cardiovasc Surg, 2010, 140(4): 864-870.
15.	Hongxin L, Lijun S, Wang ZJ, et al. Intraoperative device closure of large secundum atrial septal defects; a safe alternative to transcatheter closure. Eur J Cardiothorac Surg, 2008, 33(6): 1055-1060.
16.	Kornmann LM, Reesink KD, Reneman RS, et al. Critical appraisal of targeted ultrasound contrast agents for molecular imaging in large arteries. Ultrasound Med Biol, 2010, 36(2): 181-191.
17.	馬蘭, 吳衛華, 陸靜, 等. 經食管超聲心動圖在經胸微創室間隔缺損封堵術中的應用. 全國小兒心胸外科學術會議. 2008.
18.	胡原, 黃鵬, 羅金文, 等. 經食管超聲心動圖監測偏心型封堵器經胸微創室間隔缺損封堵術的應用. 中國醫學影像學雜志, 2015, 23(12): 917-921.
19.	Chen Q, Cao H, Zhang GC, et al. Atrioventricular block of intraoperative device closure perimembranous ventricular septal defects; a serious complication. BMC Cardiovasc Disord, 2012, 12: 21.
20.	蘇肇伉. 先天性心臟病微創手術的發展趨勢. 中國胸心血管外科臨床雜志, 2005, 12(4): 229-231.
21.	李偉, 顧偉禮, 勵峰, 等. 微創經胸小切口室間隔缺損封堵術的臨床應用. 中國胸心血管外科臨床雜志, 2016, 23(2): 191-193.

1. 中國醫師協會心血管外科醫師分會. 經胸微創室間隔缺損封堵術中國專家共識. 中華胸心血管外科雜志, 2011, 27(9): 516-518.
2. Masura J, Gavora P, Formanek A, et al. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn, 1997, 42(4): 388-393.
3. 萬連壯, 應朝暉, 姜萬維, 等. 食道超聲引導下小切口室間隔缺損封堵術的療效分析. 中國微創外科雜志, 2010, 10(11): 1024-1025.
4. Carminati M, Butera G, Chessa M, et al. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J, 2007, 28(19): 2361-2368.
5. 朱達, 賃可, 馮沅, 等. 雜交技術治療嬰幼兒及兒童肌部室間隔缺損——華西醫院經驗. 中國胸心血管外科臨床雜志, 2015, 20(2): 118-122.
6. 邢泉生. 經胸微創封堵室間隔缺損遠期結果——附615例6年隨訪. 中國循環雜志, 2013, 28(s1): 198-199.
7. Liang T, XiangJun Z, XiaoJing M, et al. New minimally invasive technique to occlude secundum atrial septal defect in 53 patients. Ann Thorac Surg, 2006, 81(4): 1417-1419.
8. Lin K, Zhu D, Tao K, et al. Hybrid perventricular device closure of doubly committed subarterial ventricular septal defects: mid-term results. Catheter Cardiovasc Interv, 2013, 82(3): E225-E232.
9. Matyal R, Wang A, Mahmood F. Percutaneous ventricular septal defect closure with amplatzer devices resulting in severe tricuspid regurgitation. Catheter Cardiovasc Interv, 2013, 82(6): E817-E820.
10. Holzer RJ, Sallehuddin A, Hijazi ZM. Surgical strategies and novel alternatives for the closure of ventricular septal defects. Expert Rev Cardiovasc Ther, 2016, 14(7): 831-841.
11. Yang Y, Gao L, Xu X, et al. Echocardiographic assessment and guidance in minimally invasive surgical device closure of perimembranous ventricular septal defects. Heart Surg Forum, 2014, 17(4): E206-E211.
12. Lee WC, Fang CY, Huang CF, et al. Predictors of atrial septal defect occluder dislodgement. Int Heart J, 2015, 56(4): 428-431.
13. Zhou D, Pan W, Guan L, et al. Transcatheter closure of perimembranous and intracristal ventricular septal defects with the SHSMA occluder. Catheter Cardiovasc Interv, 2012, 79(4): 666-674.
14. Tao K, Lin K, Shi Y, et al. Perventricular device closure of perimembranous ventricular septal defects in 61 young children: early and midterm follow-up results. J Thorac Cardiovasc Surg, 2010, 140(4): 864-870.
15. Hongxin L, Lijun S, Wang ZJ, et al. Intraoperative device closure of large secundum atrial septal defects; a safe alternative to transcatheter closure. Eur J Cardiothorac Surg, 2008, 33(6): 1055-1060.
16. Kornmann LM, Reesink KD, Reneman RS, et al. Critical appraisal of targeted ultrasound contrast agents for molecular imaging in large arteries. Ultrasound Med Biol, 2010, 36(2): 181-191.
17. 馬蘭, 吳衛華, 陸靜, 等. 經食管超聲心動圖在經胸微創室間隔缺損封堵術中的應用. 全國小兒心胸外科學術會議. 2008.
18. 胡原, 黃鵬, 羅金文, 等. 經食管超聲心動圖監測偏心型封堵器經胸微創室間隔缺損封堵術的應用. 中國醫學影像學雜志, 2015, 23(12): 917-921.
19. Chen Q, Cao H, Zhang GC, et al. Atrioventricular block of intraoperative device closure perimembranous ventricular septal defects; a serious complication. BMC Cardiovasc Disord, 2012, 12: 21.
20. 蘇肇伉. 先天性心臟病微創手術的發展趨勢. 中國胸心血管外科臨床雜志, 2005, 12(4): 229-231.
21. 李偉, 顧偉禮, 勵峰, 等. 微創經胸小切口室間隔缺損封堵術的臨床應用. 中國胸心血管外科臨床雜志, 2016, 23(2): 191-193.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Efficacy of minimally invasive transthoracic closure of atrial and ventricular septal defects

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content